Adjuvant Therapy for Melanoma Prolongs RFS [News in Brief]

PD-1 inhibitor pembrolizumab reduces recurrence risk in patients with stage III disease.

from Cancer via ola Kala on Inoreader https://ift.tt/2H2Zqfb
via IFTTT